RLS Global AB (publ)
RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.
Market Cap & Net Worth: RLS Global AB (publ) (RLS)
RLS Global AB (publ) (ST:RLS) has a market capitalization of $3.18 Million (Skr35.62 Million) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #33165 globally and #514 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RLS Global AB (publ)'s stock price Skr0.45 by its total outstanding shares 79874704 (79.87 Million).
RLS Global AB (publ) Market Cap History: 2015 to 2024
RLS Global AB (publ)'s market capitalization history from 2015 to 2024. Data shows change from $43.68 Million to $3.18 Million (-25.35% CAGR).
RLS Global AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RLS Global AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.33x
RLS Global AB (publ)'s market cap is 15.33 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $43.68 Million | $2.11 Million | -$8.88 Million | 20.70x | N/A |
| 2016 | $75.18 Million | $2.88 Million | -$13.76 Million | 26.10x | N/A |
| 2017 | $41.30 Million | $2.34 Million | -$19.33 Million | 17.67x | N/A |
| 2018 | $41.58 Million | $2.62 Million | -$21.89 Million | 15.87x | N/A |
| 2019 | $39.16 Million | $1.02 Million | -$27.29 Million | 38.28x | N/A |
| 2020 | $44.00 Million | $2.04 Million | -$20.53 Million | 21.54x | N/A |
| 2021 | $29.55 Million | $653.00K | -$11.46 Million | 45.25x | N/A |
| 2022 | $18.37 Million | $1.20 Million | -$24.37 Million | 15.33x | N/A |
Competitor Companies of RLS by Market Capitalization
Companies near RLS Global AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to RLS Global AB (publ) by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
RLS Global AB (publ) Historical Marketcap From 2015 to 2024
Between 2015 and today, RLS Global AB (publ)'s market cap moved from $43.68 Million to $ 3.18 Million, with a yearly change of -25.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | Skr3.18 Million | 0.00% |
| 2023 | Skr3.18 Million | -82.71% |
| 2022 | Skr18.37 Million | -37.83% |
| 2021 | Skr29.55 Million | -32.85% |
| 2020 | Skr44.00 Million | +12.36% |
| 2019 | Skr39.16 Million | -5.82% |
| 2018 | Skr41.58 Million | +0.69% |
| 2017 | Skr41.30 Million | -45.07% |
| 2016 | Skr75.18 Million | +72.12% |
| 2015 | Skr43.68 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 20th, 2025 the market cap of RLS Global AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.18 Million USD |
| MoneyControl | $3.18 Million USD |
| MarketWatch | $3.18 Million USD |
| marketcap.company | $3.18 Million USD |
| Reuters | $3.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.